New oral cancer drug targets immune system in advanced tumors
NCT ID NCT06425926
Summary
This early-stage study is testing a new oral medication called GIM-531 for people with advanced solid tumors that have stopped responding to standard treatments. The research will evaluate the drug's safety and effectiveness when taken alone and when combined with an existing immunotherapy. The study aims to find the right dose and see if this approach can help control cancer growth in patients who have limited treatment options.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Comprehensive Blood and Cancer Center
RECRUITINGBakersfield, California, 93309, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
HonorHealth Research Institute
RECRUITINGScottsdale, Arizona, 85258, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Intermountain Health St. Vincent Regional Hospital - Cancer Centers of Montana
RECRUITINGBillings, Montana, 59102, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Massachusetts General Hospital
RECRUITINGBoston, Massachusetts, 02114, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Providence Medical Foundation
RECRUITINGFullerton, California, 92835, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Tennessee Oncology, PLLC
RECRUITINGNashville, Tennessee, 37203, United States
Contact
-
The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate
RECRUITINGLos Angeles, California, 90025, United States
Contact Email: •••••@•••••
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
UCSF Helen Diller Family Comprehensive Cancer Center
RECRUITINGSan Francisco, California, 94143, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Cincinnati Cancer Center
RECRUITINGCincinnati, Ohio, 45267, United States
Contact
-
Virginia Commonwealth University
RECRUITINGRichmond, Virginia, 23219, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
-
Weill Cornell Medicine - New York Presbyterian Hospital
RECRUITINGNew York, New York, 10065, United States
Contact
Conditions
Explore the condition pages connected to this study.